Cite

HARVARD Citation

    Lai, W. et al. (2019). Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study. European journal of cancer. pp. 28-35. [Online]. 
  
Back to record